HopeStage
Back to all studies
Not recruitingISRCTN93724387

Effect of methylphenidate formulation on attention deficit hyperactivity disorder (ADHD)-patients' adherence to medical treatment. A comparison of Medikinet retard® (extended-release [ER]) once daily and Medikinet® (immediate-release [IR]) twice daily in children and adolescents diagnosed with ADHD

Research studyAges 6–17Germany
The study in practice

Understand this study

Who could participate?

Listed age limits: 6 years to 17 years.

Listed locations
Germany

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Not recruiting
Enrollment listed in the registry
Not clearly listed
Sponsor
Johannes Gutenberg University of Mainz (Germany)
Sponsor type
University
Study type
Other
Intervention type
Other / unclear
Locations
Germany
Age range
From 6 Years to 17 Years
Official registry ID
ISRCTN93724387
Official title
Show the full official title

Effect of methylphenidate formulation on attention deficit hyperactivity disorder (ADHD)-patients' adherence to medical treatment. A comparison of Medikinet retard® (extended-release [ER]) once daily and Medikinet® (immediate-release [IR]) twice daily in children and adolescents diagnosed with ADHD

Recruitment & locations

Not recruiting

Germany

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Johannes Gutenberg University of Mainz (Germany), a university.

Who can participate?

Listed age limits: 6 years to 17 years.

Is this study still recruiting?

The registry lists this study as not recruiting.

Want to explore more studies?

Explore studies